22123-09-7 Usage
Uses
Used in Pharmaceutical and Agrochemical Industries:
6-METHYL-4-(TRIFLUOROMETHYL)PYRID-2-YL HYDRAZINE is used as a building block for the synthesis of various pharmaceuticals and agrochemicals, contributing to the development of new compounds with unique chemical properties and improved biological activity.
Used in Medicinal Chemistry and Drug Discovery:
In the field of medicinal chemistry and drug discovery, 6-METHYL-4-(TRIFLUOROMETHYL)PYRID-2-YL HYDRAZINE serves as a key component in the creation of novel compounds with potential therapeutic applications, leveraging its ability to enhance biological activity and metabolic stability.
Used as a Reagent in Organic Synthesis:
6-METHYL-4-(TRIFLUOROMETHYL)PYRID-2-YL HYDRAZINE is also utilized as a reagent in organic synthesis, enabling the formation of new compounds with distinct chemical properties that can be further explored for various applications in chemical research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 22123-09-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,2,1,2 and 3 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 22123-09:
(7*2)+(6*2)+(5*1)+(4*2)+(3*3)+(2*0)+(1*9)=57
57 % 10 = 7
So 22123-09-7 is a valid CAS Registry Number.
InChI:InChI=1/C7H8F3N3/c1-4-2-5(7(8,9)10)3-6(12-4)13-11/h2-3H,11H2,1H3,(H,12,13)
22123-09-7Relevant academic research and scientific papers
SUBSTITUTED AZOLE DIONE COMPOUNDS WITH ANTIVIRAL ACTIVITY
-
Paragraph 00339-00341, (2021/10/02)
Provided herein are methods of using substituted azole dione compounds for treatment of viral infections.
Compounds with anti-cancer activity
-
Page/Page column 66, (2008/12/08)
Novel substituted azole diones are provided that kill cells, suppress cell proliferation, suppress cell growth, abrogate the cell cycle G2 checkpoint and/or cause adaptation to G2 cell cycle arrest. Methods of making and using the invention compounds are provided. The invention provides substituted azole diones to treat cell proliferation disorders. The invention includes the use of substituted azole diones to selectively kill or suppress cancer cells without additional anti-cancer treatment. The invention includes the use of cell cycle G2-checkpoint-abrogating substituted azole diones to selectively sensitize cancer cells to DNA damaging reagents, treatments and/or other types of anti-cancer reagents.
